Prognostic Significance of Matrix Metalloproteinase 2 and Tissue Inhibitor of Metalloproteinase 2 Expression in Prostate Cancer
- 1 March 2003
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 16 (3) , 198-205
- https://doi.org/10.1097/01.mp.0000056984.62360.6c
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Tissue Inhibitor of Metalloproteinase (TIMP)-2 Acts Synergistically with Synthetic Matrix Metalloproteinase (MMP) Inhibitors but Not with TIMP-4 to Enhance the (Membrane Type 1)-MMP-dependent Activation of Pro-MMP-2Journal of Biological Chemistry, 2000
- Matrix metalloproteinasesEuropean Journal Of Cancer, 2000
- Synthetic inhibitor of matrix metalloproteases decreases tumor growth and metastases in a syngeneic model of rat prostate cancerin vivoInternational Journal of Cancer, 2000
- Trendsin Molecular Medicine: Matrix metalloproteinases and their inhibitors in tumour growth and invasionAnnals of Medicine, 1999
- EXPRESSION OF METALLOPROTEINASE 2 AND 9 AND THEIR INHIBITORS IN RENAL CELL CARCINOMAJournal of Urology, 1998
- EXPRESSION OF MATRIX METALLOPROTEINASE-7 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 IN HUMAN PROSTATEJournal of Urology, 1998
- Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP‐1 and TIMP‐2)FEBS Letters, 1996
- Characterization of Gelatinases Linked to Extracellular Matrix Invasion in Ovarian Adenocarcinoma: Purification of Matrix Metalloproteinase 2Gynecologic Oncology, 1996
- TIMP-2 Growth-Stimulatory Activity: A Concentration- and Cell Type-Specific Response in the Presence of InsulinExperimental Cell Research, 1996
- Tumor Cell Invasion Inhibited by TIMP-2JNCI Journal of the National Cancer Institute, 1991